{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:09:52Z","timestamp":1760425792997,"version":"3.37.3"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK107991","DK102539"],"award-info":[{"award-number":["DK107991","DK102539"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL145163"],"award-info":[{"award-number":["HL145163"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sphingosine-1-phosphate (S1P) is a bioactive metabolite of sphingolipids and produced by sphingosine kinases (SphK1 and SphK2). SphK1\/S1P pathway is implicated in the progression of chronic kidney disease. However, the role of SphK1\/S1P pathway in renal injury in hypertension has not been reported. This study tested the hypothesis that SphK1\/S1P pathway mediates the kidney damage in DOCA-salt hypertensive mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Male wild type (WT) C57BL6 and SphK1 knockout (KO) mice were subjected to unilateral nephrectomy, subcutaneous implant containing 50\u2009mg of deoxycorticosterone acetate (DOCA) and 1% NaCl drinking water for 7 weeks. At the end of experiments, blood pressure data, 24\u2009h urine and kidney samples were collected. Renal mRNA levels of SphK1 were measured by real-time RT-PCR. Markers for fibrogenesis and immune cell infiltration in kidneys were detected using Western blot and immunohistochemistray analysis, respectively. The glomerular morphological changes were examined in kidney tissue slides stained with Periodic-Acid Schiff. Four groups were studied: wild type control (WT-C), WT-DOCA, KO-C and KO-DOCA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The renal SphK1 mRNA expression was significantly upregulated in WT-DOCA mice, whereas this upregulation of renal SphK1 mRNA was blocked in KO-DOCA mice. There was no difference in DOCA-salt-induced hypertension between WT and KO mice. The urinary albumin was increased in both DOCA-salt groups. However, the albuminuria was significantly lower in KO-DOCA than in WT-DOCA group. There were increases in glomerulosclerosis indices in both DOCA-salt groups, whereas the increases were also significantly lower in KO-DOCA than in WT-DOCA mice. Renal protein levels of \u03b1-smooth muscle actin were upregulated in both DOCA-salt groups, but the increase was significant lower in KO-DOCA than in WT-DOCA group. The increased staining areas of collagen detected by Sirius Red-staining in kidney tissue sections were also attenuated in KO-DOCA compared with WT-DOCA mice. In contrast, the increased infiltration of CD43+ (a T cell marker) or CD68+ (a macrophage marker) cells in DOCA-salt kidneys showed no significant difference between WT-DOCA and KO-DOCA mice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>SphK1\/S1P signaling pathway mediates kidney damage in DOCA-salt hypertensive mice independent of blood pressure and immune modulation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-020-01815-8","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T15:04:18Z","timestamp":1589209458000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice"],"prefix":"10.1186","volume":"21","author":[{"given":"Bingqing","family":"Lyu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Ying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"issue":"11","key":"1815_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/ki.2008.34","volume":"73","author":"SK Jo","year":"2008","unstructured":"Jo SK, Bajwa A, Awad AS, Lynch KR, Okusa MD. Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int. 2008;73(11):1220\u201330.","journal-title":"Kidney Int"},{"issue":"2","key":"1815_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.coph.2006.09.008","volume":"7","author":"SL Peters","year":"2007","unstructured":"Peters SL, Alewijnse AE. Sphingosine-1-phosphate signaling in the cardiovascular system. Curr Opin Pharmacol. 2007;7(2):186\u201392.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"1815_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 2012;22(1):50\u201360.","journal-title":"Trends Cell Biol"},{"issue":"44","key":"1815_CR4","doi-asserted-by":"publisher","first-page":"37118","DOI":"10.1074\/jbc.M502207200","volume":"280","author":"M Maceyka","year":"2005","unstructured":"Maceyka M, Sankala H, Hait NC, Le Stunff H, Liu H, Toman R, Collier C, Zhang M, Satin LS, Merrill AH, et al. SphK1 and SphK2, Sphingosine kinase Isoenzymes with opposing functions in Sphingolipid metabolism. J Biol Chem. 2005;280(44):37118\u201329.","journal-title":"J Biol Chem"},{"issue":"5","key":"1815_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/00041433-200210000-00004","volume":"13","author":"K Tamama","year":"2002","unstructured":"Tamama K, Okajima F. Sphingosine 1-phosphate signaling in atherosclerosis and vascular biology. Curr Opin Lipidol. 2002;13(5):489\u201395.","journal-title":"Curr Opin Lipidol"},{"key":"1815_CR6","doi-asserted-by":"crossref","unstructured":"Liu HY, Zhang ZL, Li PY, Yuan X, Zheng J, Liu JW, Bai CQ, Niu WK. Regulation of S1P receptors and sphingosine kinases expression in acute pulmonary endothelial cell injury. Peerj. 2016;4.","DOI":"10.7717\/peerj.2712"},{"issue":"1","key":"1815_CR7","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1042\/BST20110602","volume":"40","author":"NJ Pyne","year":"2012","unstructured":"Pyne NJ, Tonelli F, Lim KG, Long JS, Edwards J, Pyne S. Sphingosine 1-phosphate signalling in cancer. Biochem Soc Trans. 2012;40(1):94\u2013100.","journal-title":"Biochem Soc Trans"},{"issue":"7503","key":"1815_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nature13475","volume":"510","author":"M Maceyka","year":"2014","unstructured":"Maceyka M, Spiegel S. Sphingolipid metabolites in inflammatory disease. Nature. 2014;510(7503):58\u201367.","journal-title":"Nature"},{"issue":"3","key":"1815_CR9","doi-asserted-by":"publisher","first-page":"S126","DOI":"10.1016\/j.jamcollsurg.2014.07.300","volume":"219","author":"M Nagahashi","year":"2014","unstructured":"Nagahashi M, Yamada A, Aoyagi T, Terracina KP, Koyama Y, Wakai T, Takabe K. Sphingosine-1-phosphate signaling targeted therapy suppresses obesity-related breast Cancer progression and improves survival. J Am Coll Surgeons. 2014;219(3):S126.","journal-title":"J Am Coll Surgeons"},{"issue":"4","key":"1815_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1093\/jb\/mvs090","volume":"152","author":"Y Hisano","year":"2012","unstructured":"Hisano Y, Nishi T, Kawahara A. The functional roles of S1P in immunity. J Biochem. 2012;152(4):305\u201311.","journal-title":"J Biochem"},{"issue":"5","key":"1815_CR11","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.febslet.2004.12.094","volume":"579","author":"K Geoffroy","year":"2005","unstructured":"Geoffroy K, Troncy L, Wiernsperger N, Lagarde M, El Bawab S. Glomerular proliferation during early stages of diabetic nephropathy is associated with local increase of sphingosine-1-phosphate levels. FEBS Lett. 2005;579(5):1249\u201354.","journal-title":"FEBS Lett"},{"issue":"12","key":"1815_CR12","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/sj.ki.5002203","volume":"71","author":"LW Lai","year":"2007","unstructured":"Lai LW, Yong KC, Igarashi S, Lien YH. A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia-reperfusion injury. Kidney Int. 2007;71(12):1223\u201331.","journal-title":"Kidney Int"},{"issue":"10","key":"1815_CR13","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/ki.2010.544","volume":"79","author":"AS Awad","year":"2011","unstructured":"Awad AS, Rouse MD, Khutsishvili K, Huang L, Bolton WK, Lynch KR, Okusa MD. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 2011;79(10):1090\u20138.","journal-title":"Kidney Int"},{"issue":"12","key":"1815_CR14","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1038\/ki.2011.281","volume":"80","author":"SW Park","year":"2011","unstructured":"Park SW, Kim M, D'Agati VD, Lee HT. Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation. Kidney Int. 2011;80(12):1315\u201327.","journal-title":"Kidney Int"},{"issue":"4","key":"1815_CR15","doi-asserted-by":"publisher","first-page":"F752","DOI":"10.1152\/ajprenal.00596.2017","volume":"315","author":"X Zhang","year":"2018","unstructured":"Zhang X, Ritter JK, Li N. Sphingosine-1-phosphate pathway in renal fibrosis. Am J Physiol Renal Physiol. 2018;315(4):F752\u2013f756.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1815_CR16","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1159\/000350093","volume":"31","author":"A Koch","year":"2013","unstructured":"Koch A, Pfeilschifter J, Huwiler A. Sphingosine 1-phosphate in renal diseases. Cell Physiol Biochem. 2013;31(6):745\u201360.","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"1815_CR17","doi-asserted-by":"publisher","first-page":"R1742","DOI":"10.1152\/ajpregu.90995.2008","volume":"297","author":"LC Sturgis","year":"2009","unstructured":"Sturgis LC, Cannon JG, Schreihofer DA, Brands MW. The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6. Am J Physiol Regul Integr Comp Physiol. 2009;297(6):R1742\u20138.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"2","key":"1815_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/HJH.0b013e32834103ee","volume":"29","author":"N-E Rhaleb","year":"2011","unstructured":"Rhaleb N-E, Pokharel S, Sharma U, Carretero OA. Renal protective effects of N-acetyl-Ser-asp-Lys-pro in DOCA-salt hypertensive mice. J Hypertens. 2011;29(2):330\u20138.","journal-title":"J Hypertens"},{"issue":"6","key":"1815_CR19","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.bbadis.2012.02.002","volume":"1822","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Wang Z, Xia M, Li PL, Zhang F, Li N. Overexpression of HIF-1alpha transgene in the renal medulla attenuated salt sensitive hypertension in Dahl S rats. Biochim Biophys Acta. 2012;1822(6):936\u201341.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"1815_CR20","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1111\/j.1582-4934.2012.01590.x","volume":"16","author":"Q Zhu","year":"2012","unstructured":"Zhu Q, Liu M, Han WQ, Li PL, Wang Z, Li N. Overexpression of HIF prolyl-hydoxylase-2 transgene in the renal medulla induced a salt sensitive hypertension. J Cell Mol Med. 2012;16(11):2701\u20137.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"1815_CR21","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00109-014-1199-1","volume":"92","author":"J Hu","year":"2014","unstructured":"Hu J, Zhu Q, Xia M, Guo TL, Wang Z, Li P-L, Han W-Q, Yi F, Li N. Transplantation of mesenchymal stem cells into the renal medulla attenuated salt-sensitive hypertension in Dahl S rat. J Mol Med. 2014;92(11):1139\u201345.","journal-title":"J Mol Med"},{"issue":"7","key":"1815_CR22","doi-asserted-by":"publisher","first-page":"F621","DOI":"10.1152\/ajprenal.00344.2015","volume":"310","author":"Q Zhu","year":"2016","unstructured":"Zhu Q, Li X-X, Wang W, Hu J, Li P-L, Conley S, Li N. Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats. Am J Physiol Renal Physiol. 2016;310(7):F621\u20137.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1815_CR23","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.4049\/jimmunol.177.6.4094","volume":"177","author":"D Turnberg","year":"2006","unstructured":"Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol. 2006;177(6):4094\u2013102.","journal-title":"J Immunol"},{"issue":"10","key":"1815_CR24","doi-asserted-by":"publisher","first-page":"F1236","DOI":"10.1152\/ajprenal.00673.2013","volume":"306","author":"Z Wang","year":"2014","unstructured":"Wang Z, Zhu Q, Li PL, Dhaduk R, Zhang F, Gehr TW, Li N. Silencing of hypoxia-inducible factor-1alpha gene attenuates chronic ischemic renal injury in two-kidney, one-clip rats. Am J Physiol Renal Physiol. 2014;306(10):F1236\u201342.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1815_CR25","doi-asserted-by":"crossref","unstructured":"Thallas-Bonke V, Jha JC, Gray SP, Barit D, Haller H, Schmidt HH, Coughlan MT, Cooper ME, Forbes JM, Jandeleit-Dahm KA: Nox-4 deletion reduces oxidative stress and injury by PKC-alpha-associated mechanisms in diabetic nephropathy. Physiological reports 2014, 2(11).","DOI":"10.14814\/phy2.12192"},{"issue":"3","key":"1815_CR26","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/cvr\/cvp312","volume":"85","author":"N Takuwa","year":"2010","unstructured":"Takuwa N, Ohkura S, Takashima S, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, et al. S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res. 2010;85(3):484\u201393.","journal-title":"Cardiovasc Res"},{"issue":"1\u20132","key":"1815_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10911-016-9354-7","volume":"21","author":"M Nagahashi","year":"2016","unstructured":"Nagahashi M, Yamada A, Miyazaki H, Allegood JC, Tsuchida J, Aoyagi T, Huang WC, Terracina KP, Adams BJ, Rashid OM, et al. Interstitial fluid Sphingosine-1-phosphate in murine mammary gland and Cancer and human breast tissue and Cancer determined by novel methods. J Mammary Gland Biol Neoplasia. 2016;21(1\u20132):9\u201317.","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"50","key":"1815_CR28","doi-asserted-by":"publisher","first-page":"52487","DOI":"10.1074\/jbc.M406512200","volume":"279","author":"ML Allende","year":"2004","unstructured":"Allende ML, Sasaki T, Kawai H, Olivera A, Mi Y, van Echten-Deckert G, Hajdu R, Rosenbach M, Keohane CA, Mandala S, et al. Mice deficient in sphingosine kinase 1 are rendered lymphopenic by FTY720. J Biol Chem. 2004;279(50):52487\u201392.","journal-title":"J Biol Chem"},{"issue":"4","key":"1815_CR29","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2353\/ajpath.2009.090037","volume":"175","author":"C Li","year":"2009","unstructured":"Li C, Jiang X, Yang L, Liu X, Yue S, Li L. Involvement of sphingosine 1-phosphate (SIP)\/S1P3 signaling in cholestasis-induced liver fibrosis. Am J Pathol. 2009;175(4):1464\u201372.","journal-title":"Am J Pathol"},{"issue":"7","key":"1815_CR30","doi-asserted-by":"publisher","DOI":"10.1002\/phy2.172","volume":"1","author":"S Shiohira","year":"2013","unstructured":"Shiohira S, Yoshida T, Sugiura H, Nishida M, Nitta K, Tsuchiya K. Sphingosine-1-phosphate acts as a key molecule in the direct mediation of renal fibrosis. Physiol Rep. 2013;1(7):e00172.","journal-title":"Physiol Rep"},{"issue":"8","key":"1815_CR31","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1681\/ASN.2007121271","volume":"19","author":"T Mori","year":"2008","unstructured":"Mori T, Polichnowski A, Glocka P, Kaldunski M, Ohsaki Y, Liang M, Cowley AW Jr. High perfusion pressure accelerates renal injury in salt-sensitive hypertension. J Am Soc Nephrol. 2008;19(8):1472\u201382.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1815_CR32","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/01.HYP.0000120971.49659.6a","volume":"43","author":"T Mori","year":"2004","unstructured":"Mori T, Cowley AW Jr. Role of pressure in angiotensin II-induced renal injury: chronic servo-control of renal perfusion pressure in rats. Hypertension. 2004;43(4):752\u20139.","journal-title":"Hypertension"},{"issue":"5","key":"1815_CR33","doi-asserted-by":"publisher","first-page":"R1494","DOI":"10.1152\/ajpregu.90631.2008","volume":"295","author":"M Xia","year":"2008","unstructured":"Xia M, Li PL, Li N. Telemetric signal-driven servocontrol of renal perfusion pressure in acute and chronic rat experiments. Am J Physiol Regul Integr Comp Physiol. 2008;295(5):R1494\u2013501.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"11","key":"1815_CR34","doi-asserted-by":"publisher","first-page":"3456","DOI":"10.1093\/ndt\/gfn301","volume":"23","author":"B Klanke","year":"2008","unstructured":"Klanke B, Cordasic N, Hartner A, Schmieder RE, Veelken R, Hilgers KF. Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension *. Nephrol Dialysis Transplant. 2008;23(11):3456\u201363.","journal-title":"Nephrol Dialysis Transplant"},{"issue":"1","key":"1815_CR35","doi-asserted-by":"publisher","first-page":"C92","DOI":"10.1152\/ajpcell.00346.2018","volume":"316","author":"H Kang","year":"2019","unstructured":"Kang H, Hong Z, Zhong M, Klomp J, Bayless KJ, Mehta D, Karginov AV, Hu G, Malik AB. Piezo1 mediates angiogenesis through activation of MT1-MMP signaling. Am J Physiol Cell Physiol. 2019;316(1):C92\u2013c103.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"12","key":"1815_CR36","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1002\/jbmr.3844","volume":"34","author":"A El Jamal","year":"2019","unstructured":"El Jamal A, Briolay A, Mebarek S, Le Goff B, Blanchard F, Magne D, Brizuela L, Bougault C. Cytokine-induced and stretch-induced Sphingosine 1-phosphate production by Enthesis cells could favor abnormal ossification in Spondyloarthritis. J Bone Miner Res. 2019;34(12):2264\u201376.","journal-title":"J Bone Miner Res"},{"key":"1815_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/7651_2017_26","volume":"1697","author":"CL Duran","year":"2018","unstructured":"Duran CL, Kaunas R, Bayless KJ. S1P Synergizes with Wall Shear Stress and Other Angiogenic Factors to Induce Endothelial Cell Sprouting Responses. Methods Mol Biol (Clifton, NJ). 2018;1697:99\u2013115.","journal-title":"Methods Mol Biol (Clifton, NJ)"},{"issue":"5","key":"1815_CR38","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1093\/ndt\/gfu261","volume":"30","author":"C Zoja","year":"2014","unstructured":"Zoja C, Abbate M, Remuzzi G. Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration. Nephrol Dial Transplant. 2014;30(5):706\u201312.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1815_CR39","doi-asserted-by":"publisher","first-page":"15878","DOI":"10.1038\/s41598-017-15972-8","volume":"7","author":"J Hu","year":"2017","unstructured":"Hu J, Wang W, Zhang F, Li PL, Boini KM, Yi F, Li N. Hypoxia inducible factor-1alpha mediates the profibrotic effect of albumin in renal tubular cells. Sci Rep. 2017;7(1):15878.","journal-title":"Sci Rep"},{"issue":"4","key":"1815_CR40","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1161\/HYPERTENSIONAHA.111.177626","volume":"58","author":"Q Zhu","year":"2011","unstructured":"Zhu Q, Wang Z, Xia M, Li PL, Van Tassell BW, Abbate A, Dhaduk R, Li N. Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension. 2011;58(4):657\u201364.","journal-title":"Hypertension"},{"issue":"6","key":"1815_CR41","first-page":"1454","volume":"1833","author":"WQ Han","year":"2013","unstructured":"Han WQ, Zhu Q, Hu JP, Li PL, Zhang F, Li NJ. Hypoxia-inducible factor prolyl-hydroxylase-2 mediates transforming growth factor beta 1-induced epithelial-mesenchymal transition in renal tubular cells. Bba-Mol Cell Res. 2013;1833(6):1454\u201362.","journal-title":"Bba-Mol Cell Res"},{"issue":"9","key":"1815_CR42","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrneph.2014.114","volume":"10","author":"XM Meng","year":"2014","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY. Inflammatory processes in renal fibrosis. Nat Rev Nephrol. 2014;10(9):493\u2013503.","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"1815_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ki.1988.207","volume":"34","author":"GF Schreiner","year":"1988","unstructured":"Schreiner GF, Harris KP, Purkerson ML, Klahr S. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int. 1988;34(4):487\u201393.","journal-title":"Kidney Int"},{"issue":"1","key":"1815_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tips.2010.11.002","volume":"32","author":"H Chi","year":"2011","unstructured":"Chi H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci. 2011;32(1):16\u201324.","journal-title":"Trends Pharmacol Sci"},{"issue":"10","key":"1815_CR45","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/sj.ki.5000357","volume":"70","author":"KH Yoo","year":"2006","unstructured":"Yoo KH, Thornhill BA, Forbes MS, Coleman CM, Marcinko ES, Liaw L, Chevalier RL. Osteopontin regulates renal apoptosis and interstitial fibrosis in neonatal chronic unilateral ureteral obstruction. Kidney Int. 2006;70(10):1735\u201341.","journal-title":"Kidney Int"},{"issue":"3","key":"1815_CR46","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.117.10655","volume":"72","author":"Y Iwazu","year":"2018","unstructured":"Iwazu Y, Muto S, Ioka T, Watanabe Y, Iwazu K, Kusano E, Nagata D. Multiple sclerosis drug Fingolimod induces thrombotic Microangiopathy in Deoxycorticosterone acetate\/salt hypertension. Hypertension. 2018;72(3):776\u201384.","journal-title":"Hypertension"},{"issue":"11","key":"1815_CR47","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd3248","volume":"9","author":"V Brinkmann","year":"2010","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, Aradhye S, Burtin P. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nat Rev Drug Discov. 2010;9(11):883\u201397.","journal-title":"Nat Rev Drug Discov"},{"issue":"21","key":"1815_CR48","doi-asserted-by":"publisher","first-page":"14839","DOI":"10.1074\/jbc.M112.426726","volume":"288","author":"K Sobel","year":"2013","unstructured":"Sobel K, Menyhart K, Killer N, Renault B, Bauer Y, Studer R, Steiner B, Bolli MH, Nayler O, Gatfield J. Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling. J Biol Chem. 2013;288(21):14839\u201351.","journal-title":"J Biol Chem"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01815-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01815-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01815-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T23:25:52Z","timestamp":1620689152000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01815-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1815"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01815-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"type":"electronic","value":"1471-2369"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"14 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were approved by the Institutional Animal Care and Use Committee of the Virginia Commonwealth University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}